ABSTRACT
Quantum dots (QDs) have widespread application in many fields such as medicine and electronics. The need for understanding the potentially harmful side effects of these materials becomes clear. In this study, the toxicity of cadmium telluride quantum dots (CdTe-QDs) and bulk Cd2+ has been investigated and compared by applying metabolomics methods. The datasets were 1H-NMR data from mice plasma which had been taken from four groups of mice in different time intervals. Then, the data were analyzed by applying chemometrics methods and the metabolites were found from Human Metabolome Database (HMDB). The results showed the significant change in the level of some metabolites especially estrogenic steroids in different groups with different amounts of received Cd. The findings also indicated that steroid hormone biosynthesis, lysine biosynthesis and taurine and hypotaurine metabolism are the most affected pathways by CdTe-QDs especially in estrogenic steroids. The over-representation analysis indicated that endoplasmic reticulum, gonads, and hepatocytes are most affected. Since the pattern of metabolite alteration of CdTe-QDs with equivalent Cd2+ was similar to those of CdCl2, it was postulated that beside Cd2+ effects, the toxicity of CdTe-QDs is associated with other factors.
Subject(s)
Cadmium Compounds/toxicity , Endoplasmic Reticulum/drug effects , Liver/drug effects , Oxidative Stress/drug effects , Quantum Dots/toxicity , Tellurium/toxicity , Testis/drug effects , Animals , Cadmium/chemistry , Cadmium/toxicity , Cadmium Compounds/administration & dosage , Cadmium Compounds/chemistry , Cadmium Poisoning/enzymology , Cadmium Poisoning/metabolism , Cadmium Poisoning/pathology , Dose-Response Relationship, Drug , Endoplasmic Reticulum/enzymology , Endoplasmic Reticulum/metabolism , Injections, Intraperitoneal , Kidney/drug effects , Kidney/metabolism , Kidney/pathology , Liver/metabolism , Liver/pathology , Male , Metabolomics/methods , Mice , Organ Specificity , Particle Size , Principal Component Analysis , Quantum Dots/administration & dosage , Random Allocation , Spleen/drug effects , Spleen/metabolism , Spleen/pathology , Surface Properties , Tellurium/administration & dosage , Tellurium/chemistry , Testis/metabolism , Testis/pathology , Toxicity Tests, ChronicABSTRACT
This study investigated the protective effect of curcumin on memory loss and on the alteration of acetylcholinesterase and ectonucleotidases activities in rats exposed chronically to cadmium (Cd). Rats received Cd (1 mg/kg) and curcumin (30, 60, or 90 mg/kg) by oral gavage 5 days a week for 3 months. The animals were divided into eight groups: vehicle (saline/oil), saline/curcumin 30 mg/kg, saline/curcumin 60 mg/kg, saline/curcumin 90 mg/kg, Cd/oil, Cd/curcumin 30 mg/kg, Cd/curcumin 60 mg/kg, and Cd/curcumin 90 mg/kg. Curcumin prevented the decrease in the step-down latency induced by Cd. In cerebral cortex synaptosomes, Cd-exposed rats showed an increase in acetylcholinesterase and NTPDase (ATP and ADP as substrates) activities and a decrease in the 5'-nucleotidase activity. Curcumin was not able to prevent the effect of Cd on acetylcholinesterase activity, but it prevented the effects caused by Cd on NTPDase (ATP and ADP as substrate) and 5'-nucleotidase activities. Increased acetylcholinesterase activity was observed in different brain structures, whole blood and lymphocytes of the Cd-treated group. In addition, Cd increased lipid peroxidation in different brain structures. Higher doses of curcumin were more effective in preventing these effects. These findings show that curcumin prevented the Cd-mediated memory impairment, demonstrating that this compound has a neuroprotective role and is capable of modulating acetylcholinesterase, NTPDase, and 5'-nucleotidase activities. Finally, it highlights the possibility of using curcumin as an adjuvant against toxicological conditions involving Cd exposure. © 2015 Wiley Periodicals, Inc. Environ Toxicol 32: 70-83, 2017.
Subject(s)
Cadmium Poisoning/physiopathology , Curcumin/therapeutic use , Memory Disorders/chemically induced , Memory Disorders/prevention & control , Parasympathetic Nervous System/drug effects , Receptors, Purinergic/drug effects , Signal Transduction/drug effects , Animals , Avoidance Learning/drug effects , Cadmium Poisoning/enzymology , Curcumin/administration & dosage , Dose-Response Relationship, Drug , Electroshock , Lipid Peroxidation/drug effects , Male , Motor Activity/drug effects , Rats , Rats, Wistar , Synaptosomes/drug effects , Synaptosomes/enzymologyABSTRACT
The aim of this study was to investigate if grape juice concentrate is able to protect rat liver against cadmium toxicity. For this purpose, histopathological analysis, cytochrome C expression and immunoexpresssion of metalloproteinases (MMP) 2 and 9 were investigated. A total of 15 Wistar rats weighing 250 g on the average, and 8 weeks age were distributed into 3 groups (n=5), as follows: Control group (non-treated group, CTRL); Cadmium group (Cd) and grape juice concentrate group (Cd+GJ). Histopathological analysis revealed that liver from animals treated with grape juice concentrate improved tissue degeneration induced by cadmium intoxication. Animals intoxicated with cadmium and treated with grape juice concentrate showed higher cytochrome C gene expression in liver cells. No significant statistically differences (p>0.05) were found to MMP 2 and 9 immunoexpression between groups. Taken together, our results demonstrate that grape juice concentrate is able to prevent tissue degeneration in rat liver as a result of increasing apoptosis.
Subject(s)
Cadmium Poisoning/prevention & control , Cytochromes c/biosynthesis , Liver/drug effects , Matrix Metalloproteinase 2/biosynthesis , Matrix Metalloproteinase 9/biosynthesis , Plant Extracts/pharmacology , Vitis/chemistry , Animals , Cadmium Poisoning/enzymology , Cadmium Poisoning/pathology , Fruit and Vegetable Juices , Liver/enzymology , Liver/pathology , Male , Necrosis/enzymology , Necrosis/pathology , Necrosis/prevention & control , Protective Agents/pharmacology , RatsABSTRACT
Alpha-lipoic acid (α-LA) is an important antioxidant that is capable of regenerating other antioxidants, such as glutathione (GSH). In the present study, we examined the protective effects of α-LA against the oxidative stress and cytotoxicity induced by cadmium in human hepatoma cell lines (HepG2) and investigated if the process was mediated through regenerating GSH. Our results showed that after exposure to 25 µM cadmium for 16 h, there was a significant decrease in the cell viability and glutathione levels and a significant increase in lipid peroxidation (p<0.01) compared with untreated cells. The presence of α-LA significantly attenuated cadmium-induced cytotoxicity and lipid peroxidation, and reversed cellular GSH levels compared with cadmium-treated cells (p<0.05). Compared with the cells treated with cadmium, co-treatment with α-LA and cadmium significantly increased the activities of γ-glutamylcysteine ligase (γ-GCL), the rate limiting enzyme in GSH biosynthesis and the mRNA and the protein levels of γ-GCL catalytic subunit (GCLC) and a modifier subunit (GCLM). In conclusion, our results indicated that α-LA is an effective agent to reduce the oxidative stress and cytotoxicity induced by cadmium by regenerating GSH levels through increasing the activities and the expressions of γ-GCL.
Subject(s)
Antioxidants/metabolism , Cadmium/toxicity , Glutamate-Cysteine Ligase/metabolism , Glutathione/agonists , Hepatocytes/drug effects , Thioctic Acid/metabolism , Antioxidants/therapeutic use , Biomarkers/metabolism , Cadmium/chemistry , Cadmium Poisoning/diet therapy , Cadmium Poisoning/enzymology , Cadmium Poisoning/metabolism , Cell Survival/drug effects , Dietary Supplements , Gene Expression Regulation, Enzymologic/drug effects , Glutamate-Cysteine Ligase/genetics , Glutathione/antagonists & inhibitors , Glutathione/metabolism , Hep G2 Cells , Hepatocytes/enzymology , Hepatocytes/metabolism , Humans , Lipid Peroxidation/drug effects , Osmolar Concentration , Oxidation-Reduction , Oxidative Stress/drug effects , RNA, Messenger/metabolism , Thioctic Acid/therapeutic useABSTRACT
BACKGROUND: Cadmium is one of the potent cardiotoxic heavy metals in the environment, which induces oxidative stress, dyslipidemia and membrane disturbances in heart. Quercetin is an effective antioxidant and free radical scavenger against oxidative stress. This study was designed to evaluate the protective effect of quercetin (QE) on cardiac marker enzymes, lipid peroxidation products, lipid profile, membrane bound ATPases and antioxidant status in cadmium (Cd)-intoxicated rats. MATERIALS AND METHODS: Twenty four male albino rats were used. Cadmium induced oxidative cardiotoxicity was induced by the oral administration of Cd for four weeks. Quercetin was pretreated along with Cd for four weeks to assess its cardioprotective effect against Cd intoxication. Rats treated with vehicles alone were used as controls. RESULTS: Rats intoxicated with cadmium (5 mg/kg/day) for 4 weeks in combination with quercetin (50 mg/kg/day) respectively. Cd-induced cardiotoxicity and dyslipidemia was indicated by increased activities of marker enzymes such as creatine kinase-MB, aspartate transaminase, alanine transaminase, alkaline phosphatase and lactate dehydrogenase in serum. In addition, the levels of lipid peroxidation products and protein carbonyl contents in heart were significantly (p < 0.05) increased and the activities of enzymic antioxidants such as superoxide dismutase, catalase, glutathione peroxidase, glutathione reductase and glutathione-S-transferase in the heart and non-enzymic antioxidants such as glutathione, vitamin C and E in the heart were significantly (p < 0.05) decreased in Cd intoxicated rats. The levels total cholesterol (TC), triglycerides (TG), phospholipidis (PL), free fatty acids (FFA), LDL and VLDL were significantly (p < 0.05) increased and the level of HDL was significantly decreased in the serum of Cd-treated rats. Cd intoxication also increased the levels of TC, TG and FFA and decreased the level of PL in the heart tissue. Further Cd treatment significantly (p < 0.05) decreased the levels of membrane bound ATP ases in heart. QE treatment along with Cd showed significant protective effect on all the biochemical parameters studied. Histopathological findings of QE and Cd treated heart confirmed the biochemical findings of this study. Thus, QE protects the myocardium against Cd-induced oxidative stress and dyslipidemia in rats. CONCLUSIONS: Quercetin may be beneficial in combating the cadmium induced oxidative cardiotoxicity and dyslipidemia in rats.
Subject(s)
Cadmium Poisoning/drug therapy , Cadmium/toxicity , Dyslipidemias/drug therapy , Heart Diseases/drug therapy , Oxidative Stress/drug effects , Quercetin/pharmacology , Animals , Antioxidants/pharmacology , Cadmium Poisoning/enzymology , Cadmium Poisoning/metabolism , Dyslipidemias/chemically induced , Dyslipidemias/enzymology , Dyslipidemias/metabolism , Heart/drug effects , Heart Diseases/chemically induced , Heart Diseases/enzymology , Heart Diseases/metabolism , Male , Myocardium/enzymology , Myocardium/metabolism , Rats , Rats, WistarABSTRACT
It was shown that the activity of alpha-amylase in the pancreas tissue, intestine content and blood, as well as kinetic characteristics in different substratum concentration changed in males and females after unitary oral administration of chloride cadmium in the dose 5 mg/kg. It was revealed that, after a single administration of chloride cadmium, growth of the pancreas weight, contents of protein and activity of alpha-amylase in the pancreatic tissue increased with parallel reduction of activity of enzyme in the small intestine. In acute cadmium intoxication, functional reorganizations in the pancreas are identical to initial stages of carcinogenic shifts. Such shifts are more expressed in females in comparison with males, especially after the cadmium intoxication.
Subject(s)
Cadmium Chloride/toxicity , Cadmium Poisoning , Pancreas/enzymology , Pancreatic alpha-Amylases/blood , Administration, Oral , Animals , Cadmium Poisoning/blood , Cadmium Poisoning/enzymology , Female , Gastrointestinal Contents/chemistry , Intestine, Small/chemistry , Male , Pancreas/drug effects , Rats , Sex FactorsABSTRACT
This study determined the effect of supplementing rabbit diet with palm oil (PO) on lipid peroxidation, antioxidant enzymes and ATPases of different sections of the eyes in ocular cadmium toxicity. Twenty male New Zealand rabbits were randomly assigned to 4 groups of 5 rabbits in a study that lasted for 4 weeks. The control was given deionised water as eye drops and the other groups of rabbits were given eye drops of solution of 2mgkg(-1) body wt cadmium (as 3CdSO(4).8H(2)O). One test group was fed with the normal chow alone and the other test groups were fed with the chow fortified with either 5% or 10% palm oil. Ocular treatment of rabbit with cadmium significantly (P<0.05) reduced their weight compared with the control. Feeding the animals with palm oil (PO) improved the weights of the animals and decreased cadmium accumulation in the eye tissues. Lipid peroxidation level was raised by cadmium in the cornea, lens and retina with palm oil supplementation of the animal diet significantly (P<0.05) reducing the level of lipid peroxidation of the retina. Cadmium significantly (P<0.05) reduced antioxidant enzymes and ATPases in the eye tissues compared with the control. Feeding the rabbits with PO significantly (P<0.05) increased the activities of these enzymes in the retina to levels comparable with the control, with the 10% supplementation producing a more pronounced effect. The study shows that PO can alter cadmium accumulation, antioxidant enzymes and ATPases in ways which suggest that it offers protection of the eyes from ocular exposure to cadmium.
Subject(s)
Adenosine Triphosphatases/metabolism , Antioxidants/metabolism , Cadmium Poisoning/metabolism , Eye/metabolism , Lipid Peroxidation/drug effects , Plant Oils/pharmacology , Animals , Cadmium Poisoning/enzymology , Catalase/metabolism , Eating/drug effects , Eye/drug effects , Eye/enzymology , Feces , Male , Palm Oil , Rabbits , Superoxide Dismutase/metabolism , Weight Gain/drug effectsABSTRACT
Cadmium poisoning has been known to result in a wide variety of cellular responses, including oxidative stress and kinase activation. It has been reported that ERK is activated following acute cadmium exposure, and this response is commonly seen as a classical ERK survival mechanism. Here, we analyzed different cell types for their responses to low concentrations of cadmium poisoning. We found that there is an association between cell susceptibility to cadmium toxicity and ERK activation. This activation is atypical, since it consists of a sustained ERK phosphorylation, that lasts up to 6 days post stimulation. This activation is associated with the appearance of cleaved caspases 8 and 3, processed PARP, and irreversible damage. Pharmacological inhibition of ERK phosphorylation results in the ability of cells to resist cadmium poisoning. Our data indicate that low cadmium concentrations result in an unconventional ERK sustained phosphorylation, which in turn leads to death signaling.
Subject(s)
Cadmium Poisoning/enzymology , Cadmium Poisoning/pathology , Caspases/metabolism , Extracellular Signal-Regulated MAP Kinases/metabolism , Osteoblasts/enzymology , Osteoblasts/pathology , Animals , Apoptosis/drug effects , Cells, Cultured , Dose-Response Relationship, Drug , Enzyme Activation/drug effects , Osteoblasts/drug effects , Phosphorylation/drug effects , RatsABSTRACT
The mammalian thioredoxin reductase (TrxR) is a selenocysteine-containing flavoprotein that regulates the thioredoxin system, one of the major systems that maintain the intracellular redox balance. We previously reported that cytosolic TrxR (TrxR1), one of three mammalian TrxR isozymes, was induced by treatment with cadmium. In the present study, to study the role of cadmium-induced TrxR1 in cellular defense, we silenced the expression of TrxR1 in HeLa cells by using small interfering RNA and examined the effect of TrxR1 silencing on the sensitivity of the cells toward cadmium. We found that the gene silencing of TrxR1 had a dual effect on cadmium-induced cell death, depending on the concentration of cadmium. The TrxR1 silencing increased the sensitivity toward a low dose (less than 10 microM) of cadmium but decreased the sensitivity toward a high dose of cadmium. These results suggested that TrxR1 might play an important role in the cellular defense system against cadmium in two ways. TrxR1 might rescue the cells from a low dose of cadmium-induced moderate injury, while it might promote the death of cells severely injured by a high dose of cadmium.
Subject(s)
Cadmium Poisoning/enzymology , Cadmium Poisoning/genetics , RNA, Small Interfering/pharmacology , Thioredoxin-Disulfide Reductase/genetics , Arsenic Poisoning/enzymology , Arsenic Poisoning/genetics , Arsenic Poisoning/pathology , Blotting, Northern , Cadmium Poisoning/pathology , Cell Death/drug effects , Gene Silencing , HeLa Cells , Humans , Hydrogen Peroxide/toxicity , Mercury Poisoning/enzymology , Mercury Poisoning/genetics , Mercury Poisoning/pathology , Oxidants/toxicity , Tetrazolium Salts , Thiazoles , Thioredoxin Reductase 1 , Thioredoxin-Disulfide Reductase/biosynthesis , TransfectionABSTRACT
We assessed the exposure of fish from the Spring and Neosho Rivers in northeast Oklahoma, USA, to lead, zinc, and cadmium from historical mining in the Tri-States Mining District (TSMD). Fish (n = 74) representing six species were collected in October 2001 from six sites on the Spring and Neosho Rivers influenced to differing degrees by mining. Additional samples were obtained from the Big River, a heavily contaminated stream in eastern Missouri, USA, and from reference sites. Blood from each fish was analyzed for Pb, Zn, Cd, Fe, and hemoglobin (Hb). Blood also was analyzed for delta-aminolevulinic acid dehydratase (ALA-D) activity. The activity of ALA-D, an enzyme involved in heme synthesis, is inhibited by Pb. Concentrations of Fe and Hb were highly correlated (r = 0.89, p < 0.01) across all species and locations and typically were greater in common carp (Cyprinus carpio) than in other taxa. Concentrations of Pb, Zn, and Cd typically were greatest in fish from sites most heavily affected by mining and lowest in reference samples. The activity of ALA-D, but not concentrations of Hb or Fe, also differed significantly (p < 0.01) among sites and species. Enzyme activity was lowest in fish from mining-contaminated sites and greatest in reference fish, and was correlated negatively with Pb in most species. Statistically significant (p < 0.01) linear regression models that included negative terms for blood Pb explained as much as 68% of the total variation in ALA-D activity, but differences among taxa were highly evident. Positive correlations with Zn were documented in the combined data for channel catfish (Icralurus punctatus) and flathead catfish (Pylodictis olivaris), as has been reported for other taxa, but not in bass (Micropterus spp.) or carp. In channel catfish, ALA-D activity appeared to be more sensitive to blood Pb than in the other species investigated (i.e., threshold concentrations for inhibition were lower). Such among-species differences are consistent with previous studies. Enzyme activity was inhibited by more than 50% relative to reference sites in channel catfish from several TSMD sites. Collectively, our results indicate that Pb is both bioavailable and active biochemically in the Spring-Neosho River system.
Subject(s)
Cadmium Poisoning/blood , Fish Diseases/chemically induced , Fishes/blood , Lead Poisoning/blood , Water Pollutants, Chemical/poisoning , Animals , Cadmium/blood , Cadmium/pharmacokinetics , Cadmium Poisoning/enzymology , Environmental Exposure , Environmental Monitoring/methods , Fish Diseases/blood , Fish Diseases/enzymology , Hemoglobins/metabolism , Lead/blood , Lead/pharmacokinetics , Lead Poisoning/enzymology , Mining , Oklahoma , Porphobilinogen Synthase/metabolism , Temperature , Water Pollutants, Chemical/blood , Zinc/blood , Zinc/pharmacokinetics , Zinc/poisoningABSTRACT
Relationships between cadmium (Cd) body burden, kidney function and coumarin metabolism were investigated using two groups of 197 and 200 healthy Thais with men and women in nearly equal numbers. A mean age of one group was 30.5 years and it was 39.3 years for the other group. Of 397, 20 subjects (5%) excreted urine Cd between 1.4 microg/g and 3.8 microg/g creatinine and these subjects faced 10-15% increase in the probability of having abnormal urinary excretion of N-acetyl-beta-D-glucosaminidase (NAG-uria). The prevalence of NAG-uria varied with Cd body burden in a dose-dependent manner (chi2 = 22, P < 0.008). Also NAG-nuria was one of the three kidney effect markers tested that showed the greatest strength of correlation with urine Cd in both men and women (r = 0.48, P < 0.001). In addition, urine Cd excretion of men and women showed a positive correlation (r = 0.46 to 0.54, P < 0.001) with urine 7-hydroxycoumarin (7-OHC) excretion which was used as a marker of liver cytochrome P450 2A6 (CYP2A6) enzyme activity. Urinary Cd excretion accounted for 25% of the total variation in urine 7-OHC excretion (P < 0.001). These data suggest that Cd may increase the expression of CYP2A6 in liver, resulting in enhanced coumarin metabolism in subjects with high Cd body burden.
Subject(s)
Anticoagulants/metabolism , Aryl Hydrocarbon Hydroxylases/metabolism , Cadmium Poisoning/enzymology , Cadmium Poisoning/pathology , Coumarins/metabolism , Kidney Tubules/metabolism , Mixed Function Oxygenases/metabolism , Adult , Cadmium/urine , Cadmium Poisoning/urine , Cytochrome P-450 CYP2A6 , Dose-Response Relationship, Drug , Female , Humans , Male , Mass Spectrometry , Middle Aged , Umbelliferones/metabolismABSTRACT
Modulation of the cytochrome P450 (CYP) monooxygenase system by cadmium was investigated in male, adult DBA/2J mice treated with a single dose (16 micromol/kg body weight, i.p.) of cadmium chloride (CdCl2). Total CYP content of liver and kidney microsomes decreased maximally (56% and 85%, respectively) 24 and 18 h, respectively, after CdCl2 treatment. Progressive increases of hepatic coumarin 7-hydroxylase (COH) activity; indicative of CYP2A5 activity, relative to the total CYP content were seen at 8 h (2-fold), 12 h (3-fold), 18 h (12-fold), and 24 h (15-fold). Similar changes were seen in the kidney. Liver and kidney CYP2A5 mRNA levels increased maximally 12 and 4 h after treatment and decreased to almost half 6 h later. In contrast, kidney and liver CYP2A5 protein levels increased maximally at 18 and 24 h. The CYP2A5 mRNA levels in the kidney and liver increased after Cd treatment in Nrf2 +/+ but not in Nrf2 -/- mouse. This study demonstrates that hepatic and kidney CYP2A5 is upregulated by cadmium with a somewhat faster response in the kidney than the liver. The strong upregulation of the CYP2A5 both at mRNA and enzyme activity levels, with a simultaneous decrease in the total CYP concentration suggest an unusual mode of regulation of CYP2A5 in response to cadmium exposure, amongst the CYP enzymes. The observed decrease in the mRNA but not in protein levels after maximal induction may suggest involvement of post-transcriptional mechanisms in the regulation. Upregulation of CYP2A5 by cadmium in the Nrf2 +/+ mice but not in the Nrf2-/- mice indicates a role for this transcription factor in the regulation.
Subject(s)
Aryl Hydrocarbon Hydroxylases/biosynthesis , Cadmium Poisoning/metabolism , DNA-Binding Proteins/physiology , Kidney/enzymology , Liver/enzymology , Mixed Function Oxygenases/biosynthesis , RNA, Messenger/biosynthesis , Trans-Activators/physiology , Acute Disease , Animals , Aryl Hydrocarbon Hydroxylases/metabolism , Blotting, Northern , Blotting, Western , Cadmium Poisoning/enzymology , Cytochrome P-450 CYP2A6 , Cytochrome P450 Family 2 , Dose-Response Relationship, Drug , Kidney/drug effects , Liver/drug effects , Male , Mice , Mice, Inbred DBA , Mice, Knockout , Microsomes/enzymology , Microsomes/metabolism , Microsomes, Liver/enzymology , Microsomes, Liver/metabolism , Mixed Function Oxygenases/metabolism , NF-E2-Related Factor 2 , Reverse Transcriptase Polymerase Chain ReactionABSTRACT
Early effects of cadmium (Cd) on the structure and function of the kidney were studied in an experimental model using rats intoxicated with Cd at the levels of 5 and 50 mg Cd/l drinking water. The effect of Cd was evaluated histopathologically and biochemically. Damage to the cellular structures was assessed on the basis of histoenzymatic analyses of the activity and localization of indicator enzymes (succinate dehydrogenase, lactate dehydrogenase, glucose-6-phosphatase, Mg(2+)-dependent adenosine triphosphatase and acid phosphatase). The histochemical observations indicate that Cd causes damage to the organization and function of the nephron. Several structures, i.e. endoplasmic reticulum, mitochondrion, lysosome, cellular and intracellular membrane, as well as their biological functions, i.e. aerobic and anaerobic respiration, transport functions and biochemical processes taking place in the endoplasmic reticulum, were affected. The cytotoxic action of Cd occurs mainly in the tubules and partially also in the glomeruli. The results clearly indicate that Cd damages kidney structurally and functionally even at a relatively low level (5 mg/l) corresponding to human environmental exposure, and they confirm our previous hypothesis that the threshold for the kidney effects of Cd is less than 4.08+/-0.33 microg/g kidney wet weight and higher than 2.40+/-0.15 microg/g. The target for Cd action in the kidney is the tubules (proximal convoluted tubules and straight tubules), and disturbance in their function is the main toxic effect of Cd. Renal glomeruli are also injured, but only partially, whereas in other parts of the nephron the damage is slight. The results, together with observations reported in the first paper of the study, incline us to conclude that humans environmentally exposed to Cd are at risk of tubular damage.
Subject(s)
Cadmium/toxicity , Kidney/drug effects , Acid Phosphatase/analysis , Acid Phosphatase/metabolism , Administration, Oral , Animals , Ca(2+) Mg(2+)-ATPase/analysis , Ca(2+) Mg(2+)-ATPase/metabolism , Cadmium/administration & dosage , Cadmium Poisoning/enzymology , Cadmium Poisoning/pathology , Glucose-6-Phosphatase/analysis , Glucose-6-Phosphatase/metabolism , Histocytochemistry , Kidney/enzymology , Kidney/pathology , Kidney/ultrastructure , Kidney Tubules/drug effects , Kidney Tubules/pathology , Kidney Tubules/ultrastructure , L-Lactate Dehydrogenase/analysis , L-Lactate Dehydrogenase/metabolism , Male , Rats , Rats, Wistar , Succinate Dehydrogenase/analysis , Succinate Dehydrogenase/metabolismABSTRACT
The influence of an antioxidant agent such as N-acetyl cysteine (NAC) or mannitol on the cadmium chelating ability of monoisoamyl 2,3-dimercaptosuccinate (MiADMS) was investigated in cadmium pre-exposed rats. This ester of 2,3-dimercaptosuccinic acid (DMSA), an accepted drug for lead poisoning, being lipophilic in nature was expected to be an efficient cadmium chelator. The treatment of cadmium intoxicated animals with MiADMS reversed cadmium induced increase in blood catalase, superoxide dismutase (SOD) and malondialdehyde (MDA), liver MDA and brain SOD and MDA levels but not the decrease in blood, liver brain reduced glutathione (GSH) and increase in oxidized glutathione (GSSG) levels, consistent with the lowering of tissue cadmium burden. The administration of NAC or mannitol reversed the cadmium induced alterations in blood and liver GSH, GSSG, blood catalase, SOD, MDA, liver SOD, MDA and brain MDA levels without lowering blood and tissue cadmium contents. However, treatments with the combination of MiADMS and NAC or MiADMS and mannitol reversed these alterations as well as reduced blood and tissue cadmium concentrations. The combined treatment with MiADMS and mannitol was better than that with MiADMS and NAC, and was significantly more effective in normalizing blood, liver GSH, GSSG, brain GSSG, and their GSH/GSSG ratios than that by either of them alone. The combined treatments also improved liver and brain endogenous zinc levels, which were decreased due to cadmium toxicity. The results suggest that the administration of an antioxidant during chelation of cadmium may provide beneficial effects by reducing oxidative stress without its cadmium removing ability.
Subject(s)
Antioxidants/pharmacology , Cadmium Chloride/toxicity , Cadmium Poisoning , Chelating Agents/pharmacology , Oxidative Stress/drug effects , Succimer/analogs & derivatives , Acetylcysteine/pharmacology , Acetylcysteine/therapeutic use , Administration, Oral , Animals , Antioxidants/therapeutic use , Brain/enzymology , Brain/metabolism , Cadmium Poisoning/drug therapy , Cadmium Poisoning/enzymology , Cadmium Poisoning/metabolism , Catalase/blood , Catalase/metabolism , Chelating Agents/therapeutic use , Drug Synergism , Drug Therapy, Combination , Glutathione/blood , Glutathione/metabolism , Liver/enzymology , Liver/metabolism , Male , Malondialdehyde/blood , Malondialdehyde/metabolism , Mannitol/pharmacology , Mannitol/therapeutic use , Rats , Succimer/pharmacology , Succimer/therapeutic use , Superoxide Dismutase/blood , Superoxide Dismutase/metabolismABSTRACT
Redox changes and the secretion of inflammatory mediators were investigated in resident peritoneal macrophages of mice chronically exposed to cadmium (Cd, 15 ppm for 2 months) through drinking water. Our results showed that in vivo Cd exposure altered the redox balance in mouse peritoneal macrophages, leading to excessive production of reactive oxygen species (ROS) that overwhelmed the antioxidant defenses. It also led to increased lipid peroxidation and arachidonic acid (AA) release, higher nitric oxide and prostaglandin E(2) (PGE(2)) production, and induction of inducible nitric oxide synthase and cyclooxygenase-2 compared with control macrophages. Oxidative stress and inflammation could be important processes operating in the modulation of mouse macrophage physiology induced by chronic Cd exposure.
Subject(s)
Cadmium Poisoning/enzymology , Cadmium/toxicity , Isoenzymes/metabolism , Macrophages, Peritoneal/drug effects , Macrophages, Peritoneal/enzymology , Nitric Oxide Synthase/metabolism , Prostaglandin-Endoperoxide Synthases/metabolism , Animals , Cadmium/metabolism , Catalase/metabolism , Cyclooxygenase 2 , Dinoprostone/blood , Enzyme Induction/drug effects , Glucosephosphate Dehydrogenase/metabolism , Glutathione Peroxidase/metabolism , Immunoblotting , Isoenzymes/biosynthesis , Male , Mice , Mice, Inbred BALB C , Nitric Oxide/blood , Nitric Oxide Synthase/biosynthesis , Nitric Oxide Synthase Type II , Oxidation-Reduction , Prostaglandin-Endoperoxide Synthases/biosynthesis , Reactive Oxygen Species/metabolismABSTRACT
This paper investigates the possible link between non-workplace cadmium (Cd) exposure, cytochrome P450 expression and hypertension. We present results of our investigation into the relationships between liver and kidney Cd burdens and the abundance of the CYP isoform 4A11. Our data show associations between non-workplace Cd exposure and changes in the abundance of hepatic and renal cortical CYP4A11. In liver the levels of immunochemically detectable CYP4A11 were positively correlated with tissue Cd content while in contrast CYP4A11 abundance was inversely correlated with kidney Cd burden. These differences are most likely related to the different Cd burden of the tissues. These observations suggest the potential for involvement of Cd as a mediator of CYP4A11 expression in kidney cortex and indicate that elevations in kidney Cd content may be involved in hypertension via alteration of the expression of this particular isoform. Potential mechanisms by which Cd may alter CYP4A11 expression are discussed briefly.
Subject(s)
Cadmium Poisoning/enzymology , Cadmium/adverse effects , Cytochrome P-450 Enzyme System/metabolism , Environmental Exposure , Hypertension , Adolescent , Adult , Aged , Body Burden , Cadmium/pharmacokinetics , Child , Child, Preschool , Cytochrome P-450 CYP4A , Female , Humans , Hypertension/enzymology , Hypertension/etiology , Kidney Cortex/drug effects , Kidney Cortex/enzymology , Liver/metabolism , Male , Microsomes, Liver/drug effects , Microsomes, Liver/enzymology , Middle AgedABSTRACT
The purpose of this study was to investigate the effect of green tea catechin on the cyclooxygenase and lipoxygenase pathways in chronic cadmium-poisoned rats. Sprague-Dawley male rats weighing 100 +/- 10 g were randomly assigned to one normal and three cadmium-poisoned groups. The cadmium groups were classified as catechin-free diet group (Cd-0C), 0.25% catechin diet group (Cd-0.25C) and 0.5% catechin diet group (Cd-0.5C), in accordance with the level of catechin supplement. The phospholipase A2 activity was remarkably increased 117% in the Cd-0C group and 60% in the Cd-0.25C group compared with the normal group, and the level in the Cd-0.5C group was the same as the normal group. Activity of platelet cyclooxygenase increased 284% in the Cd-0C group, 147% in the Cd-0.25C group and 193% in the Cd-0.5C group. The synthesis of platelet thromboxane A2 (TXA2) increased 157% in the Cd-0C group and 105% in the Cd-0.25C group, compared with the normal group. The Cd-0.5C group showed the same level as the normal group. Prostacyclin (PGI2) formation in the aorta decreased 24% in the Cd-0C group and 18% in the Cd-0.25C group. The ratio of PGI2/TXA2, the thrombocyte synthesis index, decreased 70% in the Cd-0C group and 59% in the Cd-0.25C group. The activity of 5'-lipoxygenase in the polymorphonuclear leukocyte was increased 40% in the Cd-0C group as compared with the normal group. Catechin-supplemented Cd-0.25C and Cd-0.5C groups showed the level of the normal group. In this study, the observed content of leukotriene B4, which induces the inflammatory process, increased 54% in the Cd-0C group, and in catechin-supplemented groups, showed the same level as in the normal group. The serum peroxide value increased 60% in the Cd-0C group compared with the normal group; but in the Cd-0.5C group, it showed the level of the normal group. These results indicate that chronic cadmium poisoning in rats accelerates arachidonic acid metabolism. Inhibition of arachidonic acid metabolism due to catechin supplementation, however, decreases platelet aggregation and inflammatory action. In conclusion, it would appear that green tea catechin supplementation in chronic cadmium-poisoned rats inhibits the arachidonic acid cascade by regulating the activity of phospholipase A2.
Subject(s)
Arachidonic Acid/metabolism , Cadmium Poisoning/metabolism , Catechin/administration & dosage , Tea/chemistry , Animals , Cadmium Poisoning/enzymology , Dose-Response Relationship, Drug , Epoprostenol/biosynthesis , Leukotriene B4/metabolism , Lipoxygenase/metabolism , Male , Phospholipases A/drug effects , Phospholipases A/metabolism , Phospholipases A2 , Platelet Aggregation/drug effects , Prostaglandin-Endoperoxide Synthases/metabolism , Random Allocation , Rats , Rats, Sprague-Dawley , Thiobarbituric Acid Reactive Substances/metabolism , Thromboxane A2/metabolismABSTRACT
Catalase, Mn-superoxide dismutase (MnSOD) and Cu,Zn-superoxide dismutase (CuZnSOD) activities were studied in rat liver and kidney 6-48 h after CdCl(2) intraperitoneal administration or 10-30 days daily oral CdCl(2) intake in drinking water. This approach provided some indications as to the sensitivity of each enzyme to cadmium toxicity. These experiments showed that the formation of thiobarbituric acid reactive substance (TBARS) did not strictly depend on how well the antioxidant enzyme worked. From in vitro experiments it appeared that TBARS removal by vitamin E did not restore the three enzyme activities at all. As for cadmium's inhibitory mechanism on catalase activity, our data, obtained in the pH range 6.0-8.0, are a preliminary indication that the negative effect of this metal is probably due to imidazole residue binding of His-74 which is essential in the decomposition of hydrogen peroxide. Cadmium inhibition of liver mitochondrial MnSOD activity was completely removed by Mn(2+) ions, suggesting that the reducing effect on this enzyme is probably due to the substitution of cadmium for manganese. We also observed the antioxidant capacity of Mn(2+) ions, since they were able to normalize the increased TBARS levels occurring when liver mitochondria were exposed to cadmium. The reduced activity of CuZnSOD does not seem to be due to the replacement of Zn by Cd, nor to the peroxides formed. As this enzyme activity was almost completely recovered after 48 h, we hypothesize that the momentary inhibition is imputable to a cadmium/enzyme interaction. This causes some perturbation in the enzyme topography which is critical for its catalytic activity. The pathological implications linked to antioxidant enzyme disorders induced by cadmium toxicity are discussed.
Subject(s)
Cadmium Poisoning/enzymology , Cadmium/toxicity , Catalase/metabolism , Kidney/enzymology , Liver/enzymology , Superoxide Dismutase/metabolism , Administration, Oral , Animals , Antioxidants/pharmacology , Cadmium/administration & dosage , Catalase/antagonists & inhibitors , Hydrogen-Ion Concentration , Injections, Intraperitoneal , Kidney/drug effects , Liver/drug effects , Magnesium/pharmacology , Male , Mitochondria/drug effects , Mitochondria/enzymology , Proteins/metabolism , Rats , Rats, Wistar , Superoxide Dismutase/antagonists & inhibitors , Thiobarbituric Acid Reactive Substances/metabolism , Vitamin E/pharmacologyABSTRACT
A number of reports document that Fischer 344 (F344) rats are more susceptible to chemically induced liver injury than Sprague-Dawley (SD) rats. Cadmium (CdCl2), a hepatotoxicant that does not require bioactivation, was used to better define the biological events that are responsible for the differences in liver injury between F344 and SD rats. CdCl2 (3 mg/kg) produced hepatotoxicity in both rat strains, but the hepatic injury was 18-fold greater in F344 rats as assessed by plasma alanine aminotransferase (ALT) activity. This difference in toxicity was not observed when isolated hepatocytes were incubated with CdCl2 in vitro, indicating that other cell types contribute to Cd-induced hepatotoxicity in vivo. Indeed, the sieve plates of hepatic endothelial cells (EC) in F344 rats were damaged to a greater degree than EC in SD rats. Additionally, Kupffer cell (KC) inhibition reduced hepatotoxicity in both strains, suggesting that this cell type is involved in the progression of CdCl2-induced hepatotoxicity. Moreover, enhanced synthesis of heat shock protein 72 occurred earlier in the SD rat. Maximal levels of hepatic metallothionein (MT), a protein associated with cadmium tolerance, were greater in SD rats. These protective factors may limit CdCl2-induced hepatocellular injury in SD compared with F344 rats by reducing KC activation and the subsequent inflammatory response that allows for the progression of hepatic injury.
Subject(s)
Alanine Transaminase/blood , Cadmium Poisoning/enzymology , Liver/drug effects , Animals , Cadmium Chloride/administration & dosage , Cadmium Poisoning/mortality , Dose-Response Relationship, Drug , Endothelium/drug effects , Endothelium/pathology , HSP72 Heat-Shock Proteins , Heat-Shock Proteins/biosynthesis , Hepatocytes/drug effects , Hepatocytes/pathology , Hepatocytes/ultrastructure , Kupffer Cells/drug effects , Kupffer Cells/metabolism , Liver/pathology , Liver/ultrastructure , Male , Metallothionein/biosynthesis , Microscopy, Electron , Microscopy, Electron, Scanning , Rats , Rats, Inbred F344 , Rats, Sprague-DawleyABSTRACT
The urinary excretion of N-acetyl-beta-D-glucosaminidase (U-NAG) and urinary Cadmium (U-Cd) concentration, a measure of the metal load in the body, were evaluated in 28 workers exposed to Cd, to determine the relation between the two parameters. In urine from 22 exposed workers with U-Cd<2 microg/g creatinine (Cr) there was no significant difference in U-NAG value (0.98+/-0.59 U/gCr) compared to non-exposed (0.73+/-0.48 U/gCr). In the six workers with 2 microg/gCr < or =U-Cd<10 microg/gCr the U-NAG (2.32+/-0.61 U/gCr) was statistically (P<0.05) higher than in other workers. In both the U-Cd intervals examined there were no altered values of beta2-microglobulin from urine of exposed workers compared to non-exposed (<0.30 mg/l). The U-NAG isoenzymes were separated by DEAE-cellulose chromatography from urine of non-exposed subjects and exposed workers. The U-NAG isoenzyme profile in urine of non-exposed subjects showed a high percentage (about 95%) of the A (acid) form, a much lower percentage (about 4.5%) of B (basic) form and a negligible percentage (about 0.5%) of I (intermediate) form. In the urine of 22 exposed workers with U-Cd<2 microg/gCr, the percentages of U-NAG isoenzymes were not different from non-exposed. In the urine of six workers with 2 microg/gCr< or =U-Cd<10 microg/gCr the percentage (8.34+/-0.91) of isoenzyme B (U-NAG-B), a marker of lesional enzymuria, was statistically increased (P<0.05) compared to non-exposed (4.42+/-0.56). These results suggest that adopting a biological limit for U-Cd equal to 10 microg/gCr might not be sufficiently protective. The increase in U-NAG-B content at 2 microg/gCrSubject(s)
Acetylglucosaminidase/urine
, Cadmium Poisoning/enzymology
, Cadmium Poisoning/urine
, Occupational Exposure/adverse effects
, Adult
, Cadmium/urine
, Chromatography, DEAE-Cellulose
, Chromatography, Ion Exchange
, Creatinine/urine
, Female
, Humans
, Indicators and Reagents
, Isoenzymes/urine
, Male
, Middle Aged
, Spectrophotometry, Atomic
, beta 2-Microglobulin/urine